Complement and immune complexes

Research in Immunology

Volumn 147, Issue 2, 1996, Pages 103-109

  Walport, M J ^a   Davies, K A ^a  

^a RPMS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; ENDOGENOUS COMPOUND;

ANTIGEN ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; CONFERENCE PAPER; HUMAN; MACROPHAGE; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029904303     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2494(96)87182-3     Document Type: Article

References (41)

1. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium
2. Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure
3. Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates
4. Complement and the regulation of humoral immune responses
5. Hereditary C1q deficiency and systemic lupus erythematosus
6. Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac-1 antigen
7. Complement deficiencies
8. Primate erythrocyte-immune complex-clearing mechanism
9. Factors influencing the binding of large immune complexes primate erythrocyte CR1 receptor
10. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates
11. In situ immune complex formation and glomerular injury
12. A study of in vivo immune complex formation and clearance in man
13. Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction
14. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies
15. Splenic uptake of immune complexes in man is complement-dependent
16. Clearance pathways of soluble immune complexes in the pig: insights into the adaptive nature of antigen clearance in humans
17. The role of membrane receptors for C3b and C3d in phagocytosis
18. Augmentation of macrophage complement receptor function in vitro. — V. Studies on the mechanisms of ligation of macrophage Fc receptors required to trigger macrophages to signal T lymphocytes to elaborate the lymphokine that activates macrophage C3 receptors for phagocytosis
19. 123I-labelled aggregates of IgG from the circulation
20. Quantitative chemical studies on complement or alexin. — I. A method
21. Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G
22. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus
23. Hereditary nature of the behaviour of erythrocytes in the immune adherence haemagglutination phenomenon
24. Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3
25. Deficiency of the effector mechanisms of the immune response and autoimmunity
26. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits
27. A new complement function: solubilization of antigen-antibody aggregates
28. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus
29. Complement deficiency and disease
30. Prevention of immune precipitation by purified classical pathway complement components
31. Complement, membrane glycoproteins, and complement receptors: their role in regulation of the immune response
32. Complement dependence of localisation of aggregated IgG in germinal centres
33. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses
34. Complement-mediated inhibition of immune precipitation. Role of the classical and alternative pathways
35. The role of C1,C1 inhibitor and C4 in modulating immune precipitation
36. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms
37. Pathophysiology of lupus nephritis: the role of nucleosomes
38. Differences in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo
39. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface
40. Erythrocyte complement receptor type 1, immune complexes and the rheumatic diseases
41. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus